Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

The Systemic Immune-Inflammation Index (SII) is an important marker of immune function, defined as the product of neutrophil-to-lymphocyte ratio (NLR) and platelet count (P). Higher baseline SII levels have been associated with improved survival in various types of cancers, including lung cancer. Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Biswas, Tithi, Kang, Kylie H., Gawdi, Rohin, Bajor, David, Machtay, Mitchell, Jindal, Charu, Efird, Jimmy T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662688/
https://www.ncbi.nlm.nih.gov/pubmed/33143164
http://dx.doi.org/10.3390/ijerph17217995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662688/
https://www.ncbi.nlm.nih.gov/pubmed/33143164
http://dx.doi.org/10.3390/ijerph17217995

Ejemplares similares